BioCatalyst

Pacritinib, Physician's Choice medications — catalyst calendar

1 verified catalyst event(s) referencing Pacritinib, Physician's Choice medications, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-05
in 2mo
ESTIMATED
 READOUT
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polyc
Phase 3 · Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis
 Swedish Orphan Biovitrum Pacritinib, Physician's Choice medicatio ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.